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Abstract
Network-based analysis has been proven useful in biologically-oriented areas, e.g., to explore the dynamics and complexity
of biological networks. Investigating a set of networks allows deriving general knowledge about the underlying topological
and functional properties. The integrative analysis of networks typically combines networks from different studies that
investigate the same or similar research questions. In order to perform an integrative analysis it is often necessary to
compare the properties of matching edges across the data set. This identification of common edges is often burdensome
and computational intensive. Here, we present an approach that is different from inferring a new network based on
common features. Instead, we select one network as a graph prototype, which then represents a set of comparable network
objects, as it has the least average distance to all other networks in the same set. We demonstrate the usefulness of the
graph prototyping approach on a set of prostate cancer networks and a set of corresponding benign networks. We further
show that the distances within the cancer group and the benign group are statistically different depending on the utilized
distance measure.
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Introduction
Formanydiseasesnolongersinglegenesactasmarker,butasetof
interacting genes may be used to characterize or diagnose a
pathological process [1]. Driven by that rational a plethora of new
data analysis methods emerged over the last years, as the need for
methods that are able to capture the related complexities arose. A
simple example is to look for objects that are highly connected to
other objects and may therefore play a central role in regulatory
processes. The network-based analysis [2] of biological data is one
related field in systems biology [3]. Whereas classical data analysis
wasdrivenbyareductionisticpoint ofview,modernnetworkbiology
aims at perceiving the data holistically [3]. Using networks allows
leaving behind the static exploration of one feature at a time, and
enabling an investigation of the more realistic dynamic nature of
biological and medical data. The dynamics lie in several dimensions,
as systems change over time [4], react to perturbations [5] or are
simply made up by biological functions, which are interlinked into
complex cascades [6]. Simultaneously, combining different data
sources has become a standard procedure in modern computational
biology. Be it by means of data integration or classical meta-analysis,
much effort is still being put into standardizing approaches that
enable an integrative analysis [7]. Integrative approaches allow
increasing the evidence base for new findings by combining
information from different sources. In a classical view data
integration refers to the integration of data of different nature (e.g.
gene expression and proteomics). In this present paper, we also refer
to the integration of the same type of data as data integration.
Research for combining network biology and integrative data
analysis has flourished over the last years [8–10]. This allows
deriving generalizations from a set of differing networks that
investigate the same or similar research questions. Such general
findings can be used for answering biological questions or for
creating new hypothesis about underlying processes. Measuring the
similarity between networks has been proven useful for assessing
systematic effects of time course for metabolic networks [8],
matching regulatory interactions [9] or for identification of similar
subgraphs in pairs of networks [10]. Another application of
comparative network analysis is the systematic comparison of two
association networksthat weretrimmed forpartial correlations[11].
Yet, detecting and inferring knowledge about common properties
for a set of networks is a challenging task since comparing networks
depends on the definition of the underlying similarity measure.
However, the similarity between any objects is not uniquely defined
since multifaceted aspects such as structure, function and semantics
are involved [12]. Therefore, it is necessary to find comparable
features in biological networks. Often this is done by detecting
common edges or vertices, and comparing them or their
distributions [13,14]. To address the issue of meaningfully
comparing biological networks a multitude of methods has been
developed. We can here only present a small selection of these
approaches and their applications. Piruzian et al. employed
topological information for integrating transcriptomic and proteo-
mic data in a rank-based approach [15]. A generalized form of the
degree distribution, the so called graphlet degree distribution, can
be applied for determining network similarity [16]. Graphlets were
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statistical method for comparing large disease networks inferred
from cervical cancer using a tree decomposition and alignment
technique was also proposed in [18]. Here, we focus on the
application of comparing networks, that are derived from the same
type of data and are used as representations for a class of specimen.
Therefore, we analyze a set of association networks derived from
prostate cancer gene expression data. By making use of this
combination it is possible to derive generalized information about
the network-based findings related to certain diseases or develop-
mental states. A common approach to the problem of analyzing
network properties by means of meta-analysis is to compare the
overlap of edges in different networks. We demonstrated its
usefulness for a network-based integration in a previous study
[19]. A similar approach for shared edges was given by Cootes et al.
[10]. An alternative method was presented by Wang et al., who
utilized information about the effect-size to combine information
from a set of network [20]. However, this approach requires
information about the effect-size to be available. Detecting common
edges in a network is a challenging task if no proper mapping
between the vertex labels is available. When considering co-
expression networks, the vertex labels refer to gene names. In order
togeneratea commonname spaceacrossthe differentnetworks,itis
therefore useful to map the study-specific, platform-depended gene
identifiers to other identifiers, e.g. Entrez gene identifiers.
In the present paper we demonstrate an alternative approach
for inferring common topological properties for a set of networks.
Here, graph prototyping can be understood as a method that
selects an existing network from a set of networks as a
representative for the complete set, with respect to an underlying
graph distance measure [21]. This means that the structural graph
prototype represents the topological properties of a complete set of
networks, depending on the selection criterion that is defined by
the graph distance measures. A schematic illustration for selecting
a graph prototype is given in Fig. 1. Note that other definitions of
graph prototypes such as the so-called consensus tree [22] have
been also explored. But those won’t be discussed in this paper.
Thus, this prototype network can then be used for performing a
topological analysis and inferring new knowledge, as it represents
the properties of all other networks from the same set. One strong-
point of this method is that detecting common edges or nodes may
become unnecessary, depending on the employed graph distance
measures. Then, it is crucial using a graph distance measure whose
computational complexity is polynomial. To implement graph
prototyping, we select proper graph distance measures that are
able of meaningfully quantifying the distance between two
networks. As part of our contribution we describe four distance
measures that are based on the probability distributions of network
properties. This is another strong-point of this method, as it can be
modified to make use of other, customized graph distance
measures. To demonstrate the selection of a graph prototype
[21,23] we make use of prostate cancer gene expression studies.
25% of newly diagnosed male cancers in the US are prostate
cancers [24], which makes it an attractive target for ongoing
biomedical research. A broad range of studies have been
conducted over the last years, and much of the corresponding
data is available in public data repositories [25–27]. We apply our
method on a set of seven prostate cancer studies [28–24], which
consist of cancer samples and samples from benign or healthy
tissue. We expect a two-fold result: First, we expect to see
Figure 1. The graph prototyping method. This figure schematically illustrates the derivation of the graph prototype.
doi:10.1371/journal.pone.0022843.g001
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studies by making use of topological measures. Secondly, we
expect to see significant differences between the distances within
the cancer data networks and the distances within the benign data
networks. This could show that not only the networks themselves
differ, but that even the similarities between the two groups differ.
If so, the pathogenic processes that are caused by the cancer are
most likely responsible to explain these observations. Based on
previous work [19] we expect to observe higher similarities within
the cancer group. More precisely, we expect distances within data
sets from a cancer group to be smaller than those from a benign
set.
The paper is organized as follows: In the ‘Data and Methods’
section we present the exploited data sets and the inference process
of the networks. Then, we describe the graph prototyping
approach and the employed graph distance measures in detail.
The section ‘Results’ summarizes and describes the obtained
results. The section ‘Discussion and Outlook’ ends the paper with
discussing our results and is followed by some final remarks.
Materials and Methods
Prostate Cancer Data
We demonstrate the graph prototyping approach using a set
of prostate cancer studies. Since this cancer has been thoroughly
investigated for the last years, a larger number of gene
expression data is on-hand through public repositories. For
the presented study a survey on the repositories NCBI GEO
[25], EBI Arrayexpress [26] and Oncomine [27] was conducted.
For inclusion into our analysis studies have to report gene
expression levels from prostate cancer and benign specimen
using microarrays. Benign specimen are either samples from
normal tissue adjacent to tumors or healthy males. We
expurgate metastatic forms from the cancer samples for this
study in order to decrease heterogeneity in the networks. Cell
line expression data was also excluded. To reduce the data
preparation and mapping effort we only include Affymetrix
microarray platforms in this study.
For conducting this analysis we select seven data sets [28–34]
from the data pool as listed in Table 1. To investigate the effect of
sample size within the studies on our results a broad range of
sample sizes (from small studies to larger ones) is allowed. After the
selection of studies to be included, we re-perform microarray
preprocessing. The given sample sizes in Table 1 refer to the post-
quality control state. To enable inter-study comparison of the
genes, the original identifiers are mapped to Entrez gene identifiers
by using the biomaRt package [35] for Bioconductor [36].
Wherever multiple probesets map to one Entrez gene identifier,
we retain the measurement with the highest variance. After this
mapping 8906 genes common within all seven studies are left for
further analysis. For deriving a suitable network representation of
the data, the creation of association networks was chosen.
However, the methods presented below are applicable to a range
of other network types too, if adopted properly.
Network Inference
To infer a proper network representation of the underlying data
is an important challenge in network-based research [37–39]. A
broad range of network representations for biological data exist
[39–41], and the graph prototyping method presented hereinafter
can be applied for most of them. Here, we utilize information
about the association between two genes. The resulting networks
are therefore called association networks. For inferring and
analyzing gene expression data as association networks, co-
expression relationships have been often utilized [42]. Note, that
association does not necessarily indicate causality. One way to
address this problem is to apply the concept of causal memberships
[43], where genes have been functionally categorized.
Here, we utilize the mutual information as a measure for the
association, as described in [39]. For inferring the networks from
the gene expression data, we make use of the MRNETB algorithm
[38]. To set up data sets for selecting a graph prototype, we infer
two networks from each study. One network that is based on the
information from the benign samples in a study, and one network
from the cancer samples in the same study. This leads to 6 benign
networks, and 7 cancer networks, as we remove the benign
network from the Wang data. This is done due to the small sample
size (nbenign~3) since we regard the inferred network as being of
little reliability. In general, inferring a network for each patient
group separately allows performing topological comparisons and
thereby deriving new insights on the underlying functional
differences.
Selection of a Graph Prototype
To generalize the graph similarity problem [21], it has been
shown by Dehmer et al. that one graph can be used to represent a
set of other comparable graphs [21]. The task of determining this
so called graph prototype can be solved by applying distance or
similarity measures [21,44]. Let G be a network, and d(Gi,Gj) be a
graph distance measure. Having a set of networks S~fG1,
G2,:::,GjSjg, the graph prototype can be expressed by [21,23,45]:
Table 1. The data sets that were used in this study.
Name Journal Year Platform nbenign ncancer
Chandran BMC Cancer 2007 Affymetrix GeneChip HG U95Av2 15 57
Liu Cancer Res 2006 Affymetrix GeneChip HG HG-U133A 13 41
Wallace Cancer Res 2008 Affymetrix GeneChip HG U133A 2.0 14 68
Tsavachidou J Natl Cancer Inst 2009 Affymetrix GeneChip HG HG-U133A 49 23
Singh Cancer Cell 2002 Affymetrix GeneChip HG U95Av2 48 50
Yu J Clin Oncol. 2004 Affymetrix GeneChip HG U95Av2 58 59
Wang Cancer Res 2010 Affymetrix GeneChip HG HG-U133A 3{ 138
We infer the networks from public available data sets. The given sample size are after quality control and related filtering. { We do not infer a network from this group,
due to the small sample size.
doi:10.1371/journal.pone.0022843.t001
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G[S
1
jSj
X jSj
i~1
d(G,Gi): ð1Þ
We see that
1
jSj
XjSj
i~1 d(G,Gi) in Eq. 1 gives the mean distance
from network G to all other networks in S. We denote this as   d d(G).
Our goal in the present paper is to apply a selection of graph
distance measures for selecting graph prototypes from a set of
prostate cancer networks and a set of corresponding benign
networks. Applying different graph distance measures means that
we can cover different aspects of structural similarity. In general, it
is a still outstanding problem what aspect of structural similarity an
underlying measure captures [44]. If different graph distance
measures select the same network as a graph prototype for a set of
networks, this increases the validity of the selection. With respect
to the employed distance measure the graph prototype represents
the topological properties of the other networks from the same set
S. It can therefore be used for performing a topological and
functional analysis.
Graph Distance Measures
In order to perform graph prototyping it is necessary to
meaningfully measure the distance between two networks. In this
subsection we present two approaches for accomplishing this task.
The first approach is based on using inexact graph matching. In
particular, we choose the so-called graph edit distance (GED) [46].
The second approach is based on comparing two discrete
probability distributions [47], that are inferred by deriving
structural features of the networks.
The GED is the minimum cost of a sequence for transforming a
graph Gi into another graph Gj using edit operations (deleting and
inserting edges or deleting, inserting, and substituting vertices)
[46]. The underlying problem (to compare two graphs structurally)
can be seen as a generalization of Levenshtein’s method [48] for
comparing strings. Generally, calculating the GED for (unlabeled)
graphs is computationally demanding, as it is NP complete [49].
For our purpose the complexity can be reduced due to three facts
[50]: i) All of our networks Gi~1,2,...,jSj have the same number of
(unconnected) vertices jV1j,jV2j,...,jVjSjj, ii) all the vertices are
labeled uniquely, and iii) by selecting only the genes that are
present in all studies, all the networks have the same set of vertices,
which frees us of deleting, inserting or substituting any vertices.
Thus, reducing the computational complexity to O(jVj
2) [49]. For
measuring the distances between two networks, we employ a
normalized form, which is given by the percentage GED (pGED)
[51]:
pGED(Gi,Gj)~
2GED(Gi,Gj)
jVj(jVj{1)
[ ½0,1 , ð2Þ
where jVj(jVj{1) is the number of maximum possible edges in
G, and the factor 2 refers to the non-directed nature of the edges.
We weight all remaining edit transformations (insert, delete)
equally by assigning a weight of w~1.
An information-theoretic approach for quantifying distances
between graphs can be defined based on the Kullback-Leibler
divergence (KLD) [47]. We define two discrete probability
distribution P and Q, so that the KLD is given as [47]:
KLD(P,Q)~
X
i
Pi log
Pi
Qi
: ð3Þ
The KLD is always defined positively for the distance between P
and Q. Note, that KLD(P,Q)=KLD(Q,P). As the KLD is
asymmetric and does not satisfy the triangle inequality, it is no
metric [52]. We then calculate the graph prototype by setting d to
the KLD in Eq. 1. Numeric stability is ensured by setting
probabilities of zero to e~10{16.
A typically distribution that is often used in Systems Biology is
the degree distribution D(G). In undirected networks, the degree
k(vi) gives the number of neighbors for a vertex vi. If we define jkjj
to be the number of vertices with j neighbors, we can derive a
probability distribution so that:
D(G)~
X max(k)
i~1
jkij
P
jkj
~1, ð4Þ
where max(k) is the maximum number of neighboring vertices in
G. Fig. 2 shows the degree distributions of the benign and cancer
networks. D(G) can be used to characterize a network [9,42,53–
55], and has been shown to be scale-free and follow a power-law
distribution for various types of biological networks [42,53–55].
Power-law distributions of the degrees can also be seen in Fig. 2.
Here, we use D(G) to calculate the KLD, which we therefore
denote as KLD(degree).
Distances present another prominent network invariant. For a
vertex vi the distance to all other vertices is given by
z(vi)~
X jVj
j~1
p(vi,vj), ð5Þ
where p(vi,vj) is the shortest path between the vertices vi and vj.I f
we let jzlj be the cardinality of all the distances with the length l,
then the according distance distribution Z(G) is given as
Z(G)~
jz1j
E? ,
jz2j
E? ,...,
jzr(G)j
E?
  
, ð6Þ
where E? is the number of paths. We see that
Xr(G)
i~1
jzij
E? ~1.
Note, that r(G) is the diameter of G, which is the maximum of the
shortest paths between all pairs of vertices. The distance
distributions for the networks is presented in Fig. 3. We employ
the distance distributions of the included networks in order to
quantify the distance between two networks, which is denoted as
KLD(distance).
While for the three distance measures that we presented above
the complete, unconnected network was analyzed, we now present
two distance measures that work on connected graphs only. This
means that we have to infer the largest connected subgraph of
each network and apply the two distance measures to them. The
third distribution that we include in our KLD-based distance
measures is based on vertex probabilities [56]. A vertex probability
p(vi) assigns a probability value to a vertex vi by making use of a so
called vertex functional f(vi) [56]:
Integrative Network Biology
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22843Figure 2. The degree distributions. The degree distributions for the benign data (top) and the cancer data (bottom). For displaying reasons we
trimmed the number of counts at 300.
doi:10.1371/journal.pone.0022843.g002
Figure 3. The distribution of distances. The distance distributions for the benign data (top) and the cancer data (bottom).
doi:10.1371/journal.pone.0022843.g003
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f(vi)
PjVj
j~1 f(vj)
: ð7Þ
We see that
P
p(vi)~1. In this paper we utilize the following
vertex functional [56]:
f(vi) : ~c1jS1(vi,G)jzc2jS2(vi,G)jz   z
cr(G)jSr(G)(vi,G)j, ckw0:
ð8Þ
The number of vertices in the j-th sphere is given for every vertex
vi[V as jSj(vi,G)j [56]. We see that f(vi) is based on metrical
properties of graphs [57]. Here, we let the weighting factors cj
decrease in an exponential manner. This allows us to emphasize
the vertices fairly close to vi, as they are probably stronger effected
by information that spreads out from vi [56].
Finally, we use a distribution that can be calculated by using the
topological information content based on vertex orbits [58,59]. An
orbit contains topologically equivalent vertices [58], and jNV
i j
provides information about the number of vertices belonging to
the i-th vertex orbit [58]. We here determine a probability
distribution by summing up the number of orbits sharing the same
number of vertices within a network G. Let jMO
j j be the number
of orbits containing j vertices. If G has jMj vertex orbits then we
obtain the orbit distribution
M(G) : ~
jMO
1 j
jMj
,
jMO
2 j
jMj
,...,
jMO
Mj
jMj
  
: ð9Þ
Note, that
XM
i~1
jMO
i j
jMj
~1, where M is the sum of the number of
orbits containing the same number of vertices. The information
about the distribution of topological equivalent vertices in each of
our networks can then be used to combine the information for a
set of networks by the KLD. We refer to this as KLD(orbits).
With each of these four presented probability distributions we
can cover different aspects of topological properties of our
networks. The probability distribution for KLD(degree) is based
on information about how connected the genes in each of the
networks are. Information about the communication distances
between genes is reflected by the distribution that is used in
KLD(distance). KLD(spheres) is based on a probability distribu-
tion that describes the spread of information in a network, while
the probability distribution in KLD(orbits) reflects topological
equivalence of vertices. Table 2 summarizes the employed distance
measures. After having introduced our formal apparatus, we
compute the distances and graph prototype for the two sample
groups (benign and cancer). For calculations and statistical analysis
we make use of the statistical programming language R (http://
www.r-project.org). The probability distributions to calculate
KLD(spheres) and KLD(orbits) are computed using the QuACN
package [60].
Results
Table 3 provides a summary of the mean distances for the five
distance measures and the two groups. When calculating the
pGED we see that the mean distance   d d for the six networks ranges
from 0:022 to 0:053 in the benign group, and from 0:002 to 0:010
for the seven networks in the cancer group. The mean values are
0:036 (benign) and 0:004 (cancer). Fig. 4 provides an illustration of
all the single distances from one network to all others in the same
group. A distinction between the distribution of pGEDs between
the cancer and benign sample can be seen. For the benign group,
the network that is based on the data by Yu is selected as graph
prototype, while for the cancer group the network form the Wang
data is selected. The mean distance for the Yu data is 0:022 and
for the Wang data 0:002. The network-specific mean distance   d d of
the KLD(degree) ranges from 4:269 to 12:358 for the networks
from the benign data, respectively 6:498 to 20:176 for the prostate
cancer data. The mean values are 8:330 (benign) and 13:438
(cancer). Fig. 5 visualizes the results. The selected graph prototypes
are Yu (benign) with a mean distance of 4:269 and Wang (cancer)
with a mean distance of 6:498. KLD(distance), which is based on
the distance distribution within a network, selects the networks
from the Singh data (benign) and Wang data (cancer) as graph
prototypes. The graph prototypes have a mean distance   d d of 0:502
(benign) and 0:218 (cancer). The mean distances from one network
to all others in the same groups for each set are 0:934 (benign) and
0:671 (cancer). The detailed results are depicted in Fig. 6. The
networks from Yu (benign) and Wang (cancer) are again selected
as graph prototypes when using KLD(spheres). The minimum   d d is
3:525 for the benign graph prototype, respectively 6:434 for the
cancer graph prototype. The mean values are 7:351 (benign) and
13:078 (cancer). The distances from one network to all other
networks within the same group are illustrated as boxplots in Fig. 7.
Together with the KLD(degree) this represents the two cases,
where the distance within the cancer data is larger then within the
benign data. For the measure based on the orbits KLD(orbits) the
distances of the graph prototypes are 0:052 for the benign Yu
network and 0:032 for the cancer network that is based on the
Wang data. The mean distances are 0:163 (benign) and 0:082
(cancer), as shown in Fig. 8.
Our main hypothesis is that there is a significant difference
between the distances in the group of cancer samples and the
distances in the group of benign samples. For testing this
Table 2. The employed distance measures.
Name Type Description
pGED Normalized graph edit distance Minimization of a sequence of morphological graph edit operations that are needed to make two networks isomorph [46].
KLD(degree) Kullback-Leibler divergence Comparison of the degree distributions of two networks.
KLD(distance) Kullback-Leibler divergence Comparison of the distance distributions of two networks.
KLD(spheres) Kullback-Leibler divergence Comparison of the sphere-based vertex probabilities of two networks.
KLD(orbits) Kullback-Leibler divergence Comparison of the distribution of the number of topologically equivalent vertices of two networks.
Here, we list the 5 distance measures that were used for the selection of a graph prototype.
doi:10.1371/journal.pone.0022843.t002
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five distance measures on the set of distances from the cancer
samples and the benign samples. We correct for multiple testing
with the Bonferroni method. pGED, KLD(degree), KLD(spheres)
exhibit a significant difference (pBonfv0:05), as can be seen in
Table 4. The observed results support the hypothesis, see boxplots
in the related figures.
For detecting patterns within the set of distances we employ
clustering. Therefore, we normalize the result of each distance
measure without the group information. This is done for each
distance measure separately, so that the minimum of each distance
measure is set to 0 and the maximum to 1. Then we apply
hierarchical clustering. For each network we have a feature vector,
that consists of the mean distance to all other networks for each of
the five utilized distance measures. So, for the overall clustering we
have a matrix with 5 rows and 13 columns. The corresponding
heatmap, using the Euclidian distance and complete linkage, is
depicted in Fig. 9. We also applied average linkage as clustering
function, which lead to the same result. We therefore regard the
observed outcome as stable with respect to these two linkage
functions. The results show that three of the cancer networks
(Tsavachidou, Wallace, Singh, Liu) form a separate cluster, while
all other networks are clustered together. In the second cluster we
observe that three of the cancer networks (Chandran, Wang, and
Yu) cluster closely to three benign networks (Yu, Singh,
Tsavachidou).
Based on the results from the graph prototyping we select the
network from the Yu data as graph prototype for the benign set,
and the network from the Wang data as graph prototype for the
cancer set. For the analysis of the topological properties of the
Table 3. Ranges of mean distances   d d.
benign cancer
min mean max min mean max
pGED 0.022 0.036 0.053 0.002 0.004 0.010
KLD(degree) 4.269 8.330 12.358 6.498 13.438 20.176
KLD(distance) 0.502 0.934 1.280 0.218 0.671 1.900
KLD(spheres) 3.525 7.351 9.979 6.434 13.078 18.534
KLD(orbits) 0.052 0.163 0.333 0.032 0.082 0.184
For each distance measure that is applied, we here list a summary of the results, based on the mean distances   d d from one network to all other networks belonging to
the same group (benign or cancer). This table shows the corresponding range and the mean values.
doi:10.1371/journal.pone.0022843.t003
Figure 4. The results for pGED. This figure illustrates the distances from one network to all other networks, based on the normalized Graph Edit
Distance pGED. In the left part it depicts the distances between one benign network and all other benign networks, whereas in the right part it lists
the distances for one cancer network to all other cancer networks. The networks that are selected as graph prototypes are highlighted in different
colors (benign=blue, cancer=brown).
doi:10.1371/journal.pone.0022843.g004
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PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22843Figure 5. The results for KLD(degree). Here, we show the distances between one network and all other networks as boxplots, measured by the
Kullback-Leibler divergence, which was based on the degree distribution. In the left part we show the benign data, and in the right part the distances
from the cancer data. The graph prototypes are highlighted.
doi:10.1371/journal.pone.0022843.g005
Figure 6. The results for KLD(distance). This figure displays the distances between the networks as boxplots. The distances are based on the
distribution of distances between vertices and the Kullback-Leibler divergence. In the left part are the distances between the benign networks, and in
the right part the distances between the cancer networks.
doi:10.1371/journal.pone.0022843.g006
Integrative Network Biology
PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22843Figure 7. The results for KLD(spheres). Here, we display the distances based on the Kullback-Leibler divergence, based on the sphere vertex
functionals. In the left part we show the benign samples and in the right part the distances for the cancer samples. The selected graph prototypes are
highlighted.
doi:10.1371/journal.pone.0022843.g007
Figure 8. The results for KLD(orbits). This figure illustrates the Kullback-Leibler divergences for the orbit probability distributions. In the left part it
lists the benign samples, and in the right part the cancer samples from the studies.
doi:10.1371/journal.pone.0022843.g008
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mostly connected hub degrees is shown in Table 5. We observe
that the main hub genes in the cancer network are remarkably
smaller than those in the benign network. This is in accordance
with known results for which we applied edge vote counting for the
integrative network analysis [19]. In that study we also observed
fairly small degrees in the common cancer network. A dysregu-
lation of hub genes, associated with the cell-cycle, may play an
major role in the development of an aggressive form of prostate
cancer [61]. Similar to other scale-free networks [62,63], biological
networks may be vulnerable to attacks against a the few central
hub genes. However, it has been recently shown that hub genes do
not necessarily qualify as being fragile, and that other measures for
this property might be more appropriate [64]. Analyzing the
distances between vertices allows characterizing communication
processes in a biological network. Therefore, we explore the
distances between the vertices in the two graph prototypes. By
definition, the eccentricity s(vi) of a vertex vi is the maximum of
Table 4. Wilcoxon tests on distance measures results.
pp Bonf W
pGED v0:001 v0:001{ 92
KLD(degree) 0.004 0.018{ 883
KLD(distance) 0.114 0.570 491
KLD(spheres) 0.001 0.005{ 914
LD(orbits) 0.032 0.158 442
In order to test whether we could really see statically significant differences
between the distances in the cancer network distances and the benign network
distances we apply two-sided Wilcoxon tests. pBonf reports the p-values after
multiple hypothesis correction as suggested by Bonferroni. W is the test
statistic. { indicates a significant difference between the distances within cancer
networks and the distances within the benign networks (pBonf v0:05).
doi:10.1371/journal.pone.0022843.t004
Figure 9. Heatmap of mean distances. We here show the mean distance from one network to the other networks within the same group (benign
or cancer). For clustering we then omitted the group information. We independently add the group information as brown bars (cancer) and blue bars
(benign).
doi:10.1371/journal.pone.0022843.g009
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PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22843the shortest paths from vi to all other vertices vj[V. For the benign
graph prototype the majority of vertices have a s(vi) of 10, while
for the cancer graph prototype the majority of vertices have a s(vi)
of 1. We compare the eccentricity distributions of the two networks
with a Kolmogorov-Smirnov test, which results in a highly
significant difference (pv0:001). Another interesting network
characteristic is the network diameter r(G), which is the
maximum of all s(vi)[V. For the two graph prototypes the
diameters are 17 (benign) and 12 (cancer). However, when
analyzing the average path length in the largest connected
components of the graphs we find it to be 4:905 for the benign
graph prototype and 4:033 for the cancer graph prototype.
Furthermore, we see only a small difference in the average
clustering coefficients 0:217 (benign) and 0:268 (cancer), which is
the mean of the local clustering coefficient [65].
Discussion
In this paper we applied a method for selecting prototypical
networks for two sets of biological networks. One set of networks
was based on prostate cancer data, and the other set on data from
benign samples. We employed a selection of five distance
measures for the task of selecting the group-specific graph
prototype. The first method was a classical graph distance
measure [46], while the other four were based on using an
information-theoretic approach [47]. We then compared the
distances from all networks in the cancer group with the distances
in the benign group for all five distance measures by a Wilcoxon
test (see Table 4).
When applying the graph prototype method the interpretation
of the results is intricate. It is necessary to understand what kind
of information is captured by a graph distance measure, in order
to interpret the selection of the graph prototypes. For instance
for pGED we conclude that the graph prototype is the graph that
in average needs the least number of morphological operations
to reach morphological equivalence to all other graphs.
Interpreting the KLD-based results is more difficult since they
withhold direct information on the underlying measures, but
refer to the distances between the distributions of topological
properties. So, the gained information tells about the distances
between the distributions for the used topological network
measures but does not allow for direct interpretation of the
underlying topological network measures themselves. Most of the
existing graph similarity measures are either computationally
demanding (NP-complete in the case of unlabeled graphs) or
expect the graphs to be uniquely labeled in order to ensure
efficient computation. Three of the presented information-
theoretic distance measures do not rely on the graphs to be
labeled uniquely, but still demonstrate acceptable computational
performance, as they rely solely on the distribution of the
underlying features. This also effects the phase of data
preparation and network inference. Here, we had to first map
the microarray-specific probe-set ids to a common identifier
(Entrez gene), and then infer the underlying networks for pGED
and KLD(spheres) to work efficiently. In other cases, where a
distance measure is applied that is independent of vertex labels,
no mapping is required. This issue is of importance with respect
to classical network meta-analysis methods that are based on
counting common edges [10,19] or summarizing the effect-sizes
of common edges [20]. Then, the identification of common
edges is a crucial requirement for the employed methods. In the
present paper, we demonstrated an approach that is in principle
independent of this requirement.
To investigate a potential systematic effect caused by the
cancer, we performed a Wilcoxon test on the set of distances
between cancer and benign networks. The results indicate that a
systematic effect is likely to be present as we can see significant
differences (pBonfv0:05) for three out of five graph distance
measures. When considering the pGED as a gold standard
distance measure, we can find the following: Firstly, there is a
statistically significant difference between the distances in the
benign data and the cancer data (pBonfv0:001), and secondly
these distances are much smaller within the cancer data.
Additionally, the two networks are selected as graph prototypes
that are selected by most other distance measures as well. We also
observe that within the benign data two clusters are formed, as
can be seen in the boxplots for the measures pGED,
KLD(degree), KLD(orbits),a n dKLD(spheres). Our observation
is also reflected by the hierarchical clustering (Fig. 9). The three
benign networks (Chandran, Liu, Wallace) that form a cluster of
their own have a fairly small sample size (nbenign~15,13,14). This
might be the main reason for the clustering result. However, this
needs to be further validated with additional data in future
studies. We demonstrated in previous work that complex
quantitative graph measures are capable of capturing differences
in the underlying topology of biological networks for prostate
cancer samples and benign samples [66]. This indicates that the
cancer causes functional changes to sets of genes that are reflected
in changes of structural properties. One structural change that we
observed is related to the degree distribution, as the hub genes in
the cancer graph prototype are remarkably smaller than those in
the benign graph prototype. The topological analysis of the graph
prototypes leads us to hypothesize that the prostate cancer is
rewiring the communication paths in the diseased cells. By
intuition it is possible to assume that the flow of information takes
longer in networks with a larger diameter [67]. A topological
analysis of different signaling networks by Schramm et al. led to
similar results for prostate cancer and cancer in general [68].
They observed a slight decrease in the average path length for
Table 5. Distribution of main hubs in graph protoypes.
benign
j 107 105 96 91 88 87 86 85 84 83 82 79 77 75 74
jkjj 111123111221232
cancer
j 19 18 17 16 14 13 12 11 10 9 8 7 6 5 4
jkjj 111221 6 2322 3 1 2 1 1 63 5 4 4
We list the distribution of the 15 main hub gene degrees in the two graph prototypes. Here, jkjj is the number of genes with j neighbors.
doi:10.1371/journal.pone.0022843.t005
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cancer networks [68]. Schramm et al. also observed a decrease in
local clustering coefficients for cancer networks [68], which we
could not observe in our graph prototypes. However, in their
networks for prostate cancer one network exhibited a small
increase in the local clustering coefficient, so this calls for a
further analysis. As they investigated one network from the same
data we did select as the cancer graph prototype (Wang [34]), the
overlap in the results is no surprise. Still, by graph prototyping we
came to similar conclusions with respect to cancer networks as
they did in their study. For a topological analysis, Wang et al.
investigated the role of hub genes in aggressive forms of prostate
cancer [61]. They observed dysregulations in genes that are
related to the cell-cycle [61]. Our goal is now to identify further
structural changes they might be used as markers for disease-
specific events.
Taking the sample size of the single studies into account shows
that four out of five times the network from the largest study
(nbenign~58) was selected as graph prototype for the benign data.
In the case of the cancer data the network from the largest study
(ncancer~138) is always selected. This leads us to conclude that
the network that was inferred from the largest study, represents
all the other networks the best. The sensitivity regarding the
sample size, which massively influences the quality of the inferred
network, is also reflected by the hierarchical clustering. However,
this quite intuitive hypothesis needs further verification in future
work. Therefore we plan on pursuing a twofold approach: On the
one hand by calculating more distance measures on the present
data and, on the other hand, by testing the employed methods on
new networks. This should also allow investigating how the
distances are distributed in other types of cancer or even in other
diseases. Interestingly, whenever a distance measure showed a
significant difference between benign and cancer network
distances, the same networks were selected as graph prototype:
The Wang data for the cancer networks and the Yu data for the
benign networks. This coherence might indicate that the more
specific a used distance measure captures group (benign or
cancer) information the better is works for the selection of a graph
prototype.
The selected graph prototypes might be thought of as structural
prototypes for the available set of networks. This means that, with
respect to the employed distance measure, the graph prototypes
represent the topological properties of the entire set of networks.
Therefore, the information that is based on the topological
properties of the graph prototype can be used for succeeding
network analysis. However, the outcome depends directly on the
quality of the set of networks. Note, that this approach always
selects one network as being representative for the set, regardless of
the underlying distances. The selection alone is therefore primarily
no measure for the quality of a single study or the used inference
method, but a result driven by the selected distance measure. The
employed distance measure and the related quality of the result
have to be considered in order to assess the outcome quality. An
upper threshold for the average distance might be introduced to
force meaningful selections, but was disregarded in this present
study. A topic that has been omitted from our analysis so far is
semantic similarity between networks. We expect functional
similarity to be of importance when comparing biological data,
and therefore plan on investigating the role of semantic relatedness
in more detail. This would enable us to not only integrate
topological information, but a whole set of other potential distance
and similarity measures.
The presented methods provide a consistent and reproducible
procedure for performing integrative network analysis. As the
quality assessment for inferred networks is a challenge in systems
biology, using the presented methodology helps to address this
issue by quantifying inner-group and outer-group similarity in
simple way. It can also be used to determine the quality of a newly
inferred network, by comparing it to a set of existing networks. If
the observed distances lie within a certain range of validity the
network might be considered of reasonable quality or even as new
prototype for this set. Whereas, if it differs strongly from all other
networks it might be considered as being potentially erroneous. A
possible application of this method is to assess the quality of
trimming for indirect linkages or partial correlations as addressed
by [42]. This could be done by performing graph prototyping
before and after the trimming and comparing the two sets of
networks. We are confident that in a similar manner as classical
meta-analysis has now become a standard method for gene
expression data, the integrative analysis of network information
will become a common procedure in future systems biology
applications. A broad range of methods for quantitative network
analysis in this research field is currently emerging. Therefore,
finding and developing methods and applications for a combined
analysis is an ongoing challenge, yet open for defining standard
methods and tools. Our presented method brings the advantage of
being easily adoptable to other distance measures, that captures
the underlying information better.
Conclusion
It is a challenging task to infer common topological properties
from a set of networks. Frequently, this is done by detecting
common edges, which is, however, a burdensome procedure.
Different vertex labels from different platforms make it hard to
infer what edges are common. Finding common vertex labels is
however often challenging. Our goal in this paper was to
employ an alternative approach, that is independent from
mapping vertex labels. We tackled this problem by selecting one
network from a set of networks to be a representative for the
complete set. This structural graph prototype was then used for
succeeding topological analysis. To perform a comparative
analysis thereof, we introduced four information-theoretic graph
distance measures. Our initial hypothesis was that the distances
between networks differ significantly between the group of
prostate cancer networks and the group of benign networks. For
three out of five employed graph distance measures we
positively tested the initial hypothesis using a Wilcoxon test
(pBonfv0:05). As future work, we will investigate other diseases
as well and perform graph prototyping on other types of
biological networks.
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